enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Diroximel fumarate - Wikipedia

   en.wikipedia.org/wiki/Diroximel_fumarate

   No systematic studies of adverse effects under diroximel fumarate are available. The most common side effects in studies with dimethyl fumarate were flushing (in 34% of patients treated with the drug, versus 5% in the placebo group) and gastrointestinal effects such as diarrhoea (14% versus 10%), nausea (12% versus 9%), abdominal pain (9% versus 4%), vomiting (8% versus 5%), and indigestion (5 ...

3. Dimethyl fumarate - Wikipedia

   en.wikipedia.org/wiki/Dimethyl_fumarate

   Dimethyl fumarate (DMF) is the methyl ester of fumaric acid and is named after the earth smoke plant (Fumaria officinalis). [8] Dimethyl fumarate combined with three other fumaric acid esters (FAEs) is solely licensed in Germany as an oral therapy for psoriasis (brand name Fumaderm). [9]

4. Management of multiple sclerosis - Wikipedia

   en.wikipedia.org/wiki/Management_of_multiple...

   [16] [40] In 2013 one further oral drug, dimethyl fumarate -or BG12- (which is an improved version of fumaric acid, an already existing drug), was approved by the FDA. Another oral drug, cladribine, was approved in Russia and Australia in 2010. Its application was rejected by the FDA and EMEA in 2011, due to safety concerns.

5. US Patent Office Grants Patent Claiming Dosing Regimen for ...

   www.aol.com/news/2013-03-19-us-patent-office...

   The article US Patent Office Grants Patent Claiming Dosing Regimen for TECFIDERA™ (Dimethyl Fumarate) originally appeared on Fool.com. Try any of our Foolish newsletter services free for 30 days .

6. Modified-release dosage - Wikipedia

   en.wikipedia.org/wiki/Modified-release_dosage

   Modified-release dosage is a mechanism that (in contrast to immediate-release dosage) delivers a drug with a delay after its administration (delayed-release dosage) or for a prolonged period of time (extended-release [ER, XR, XL] dosage) or to a specific target in the body (targeted-release dosage). [1]

7. Multiple sclerosis drug pipeline - Wikipedia

   en.wikipedia.org/wiki/Multiple_sclerosis_drug...

   As of 2016, there are 10 active principles approved which are: Two interferons (interferon beta-1a and interferon beta-1b), glatiramer acetate, mitoxantrone, fingolimod, teriflunomide, [2] dimethyl fumarate [3] and finally three monoclonal antibodies (natalizumab, alemtuzumab [16] and since May 2016, daclizumab [29] [30])

8. FDA recalls thousands of antidepressant bottles due to ... - AOL

   www.aol.com/news/fda-recalls-thousands...

   The agency is specifically recalling 7,107 bottles of duloxetine delayed-release capsules manufactured by Towa Pharmaceutical Europe. The capsules are 20 milligram doses and come in bottles of 500 ...

9. Danicopan - Wikipedia

   en.wikipedia.org/wiki/Danicopan

   Danicopan, sold under the brand name Voydeya, is a medication used for the treatment of paroxysmal nocturnal hemoglobinuria. [6] [7] It is a complement inhibitor which reversibly binds to factor D to prevent alternative pathway-mediated hemolysis and deposition of complement C3 proteins on red blood cells.